|
Δ-cps1 Mutant as a Target to Detect Coccidioides Immunity
This technology is a diagnostic platform that utilizes Flow Link Immunosorbent Assay (FLISA) and Δ-cps1, a live attenuated strain of Coccidioides posadasii, to detect if an individual (including animals) has mounted a response to coccidioidomycosis either from infection or vaccination. Δ-cps1 can be used as a stimulus to detect cellular...
Published: 10/10/2025
|
Inventor(s): Daniel Powell, Lisa Shubitz, Marc Orbach, John Galgiani
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios > Immunology, Autoimmune & Inflammation, Technology Classifications > Life Sciences > Diagnostics, Technology Classifications > Veterinary Medicine > Diagnostics, Technology Classifications > Medical Devices > Diagnostic
|
|
Predictive mRNA Biomarker for Progressive Coccidioidomycosis When Infected
This invention introduces a blood-based diagnostic test to assess coccidioidomycosis progression risk. The test is broken down into three overall steps: 1) blood collection, 2) ex vivo stimulation, and 3) mRNA quantification. This technology identified a predictive a gene set/biomarkers for coccidioidomycosis that was independently validated across...
Published: 7/22/2025
|
Inventor(s): John Galgiani, Yves Lussier
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios > Infectious Diseases, Technology Classifications > Life Sciences > Biomarkers, Technology Classifications > Research Tools
|
|
Antibody Test for Coccidioidomycosis
This invention is a novel diagnostic test for coccidioidomycosis, also known as valley fever.
Background:
Valley fever (coccidioidomycosis) is a fungal disease that is a common cause for pneumonia due to spores that are swept through the air. The fungal infection can be identified in microscopic detection of specific cells within bodily fluids....
Published: 6/6/2024
|
Inventor(s): John Galgiani, Michael Johnson
Keywords(s):
Category(s): Technology Classifications > Veterinary Medicine > Diagnostics, Technology Classifications > Life Sciences > Diagnostics, Technology Classifications > Healthcare Portfolios > Infectious Diseases
|
